Literature DB >> 18008236

Toll-like receptor modulation of murine cerebral malaria is dependent on the genetic background of the host.

Jason W Griffith1, Christine O'Connor, Ken Bernard, Terrence Town, Daniel R Goldstein, Richard Bucala.   

Abstract

Infection with Plasmodium berghei ANKA is a well-established model of human cerebral malaria (CM). We show herein that Toll-like receptor (TLR) signaling influences the development of lethal CM in P. berghei ANKA-infected mice. Modulation of outcome was dependent on genetic background, such that deletion of myeloid differentiation factor (MyD) 88 on the susceptible C57BL/6 background resulted in resistance to CM, whereas deletion of MyD88 on the resistant BALB/c background led to increased mortality. Our data show that MyD88 influenced the production of T helper-polarizing cytokines, including interferon (IFN)- gamma, interleukin (IL)-4, and IL-17, as well as the total number of Foxp3(+) regulatory T (T(reg)) cells in a manner dependent on host genetic background. In addition, mRNA levels of IFN- gamma, CXCL10, and CXCL9 were strongly up-regulated in the brains of susceptible wild-type but not MyD88(-/-) infected mice. These results suggest that TLR signaling and host genetic background influences the pathogenesis of CM via modulation of cytokine production and T(reg) cell numbers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18008236     DOI: 10.1086/522865

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  33 in total

1.  A Plasmodium-encoded cytokine suppresses T-cell immunity during malaria.

Authors:  Tiffany Sun; Thomas Holowka; Yan Song; Swen Zierow; Lin Leng; Yibang Chen; Huabao Xiong; Jason Griffith; Mehdi Nouraie; Philip E Thuma; Elias Lolis; Chris J Janse; Victor R Gordeuk; Kevin Augustijn; Richard Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

2.  Distinct clinical and immunologic profiles in severe malarial anemia and cerebral malaria in Zambia.

Authors:  Philip E Thuma; Janneke van Dijk; Rick Bucala; Zufan Debebe; Sergei Nekhai; Thea Kuddo; Mehdi Nouraie; Günter Weiss; Victor R Gordeuk
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

Review 3.  The yin and yang of protein kinase C-theta (PKCθ): a novel drug target for selective immunosuppression.

Authors:  Elizabeth Yan Zhang; Kok-Fai Kong; Amnon Altman
Journal:  Adv Pharmacol       Date:  2013

4.  Toll-like receptor 7 mediates early innate immune responses to malaria.

Authors:  Alyssa Baccarella; Mary F Fontana; Eunice C Chen; Charles C Kim
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

5.  Experimental cerebral malaria progresses independently of the Nlrp3 inflammasome.

Authors:  Thornik Reimer; Michael H Shaw; Luigi Franchi; Cevayir Coban; Ken J Ishii; Shizuo Akira; Toshihiro Horii; Ana Rodriguez; Gabriel Núñez
Journal:  Eur J Immunol       Date:  2010-03       Impact factor: 5.532

Review 6.  Monocyte-derived dendritic cells in malaria.

Authors:  Isabella C Hirako; Patrícia A Assis; Bruno Galvão-Filho; Andrew D Luster; Lis Rv Antonelli; Ricardo T Gazzinelli
Journal:  Curr Opin Microbiol       Date:  2019-09-19       Impact factor: 7.934

7.  Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria.

Authors:  Gabriele S V Campanella; Andrew M Tager; Joseph K El Khoury; Seddon Y Thomas; Tabitha A Abrazinski; Lindsay A Manice; Richard A Colvin; Andrew D Luster
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-17       Impact factor: 11.205

8.  Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation.

Authors:  Kevin N Couper; Tom Barnes; Julius C R Hafalla; Valery Combes; Bernhard Ryffel; Thomas Secher; Georges E Grau; Eleanor M Riley; J Brian de Souza
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

9.  Oral activated charcoal prevents experimental cerebral malaria in mice and in a randomized controlled clinical trial in man did not interfere with the pharmacokinetics of parenteral artesunate.

Authors:  J Brian de Souza; Uduak Okomo; Neal D Alexander; Naveed Aziz; Benjamin M J Owens; Harparkash Kaur; Momodou Jasseh; Sant Muangnoicharoen; Percy F Sumariwalla; David C Warhurst; Stephen A Ward; David J Conway; Luis Ulloa; Kevin J Tracey; Brian M J Foxwell; Paul M Kaye; Michael Walther
Journal:  PLoS One       Date:  2010-04-15       Impact factor: 3.240

10.  Pathogenic roles of CD14, galectin-3, and OX40 during experimental cerebral malaria in mice.

Authors:  Miranda S Oakley; Victoria Majam; Babita Mahajan; Noel Gerald; Vivek Anantharaman; Jerrold M Ward; Lawrence J Faucette; Thomas F McCutchan; Hong Zheng; Masaki Terabe; Jay A Berzofsky; L Aravind; Sanjai Kumar
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.